Selected research
Industry Research
Sotalol Industry Research Report 2026
Market perspective
The global Sotalol market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Sotalol is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Sotalol is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Sotalol is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Sotalol include Shaanxi Hanjiang Pharmaceutical Group, GSK, Bayer, Samarth Pharma Pvt. Ltd., Cipla Limited, Cambrex, Bristol-Myers Squibb (BMS), Arevipharma and Arbor Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Sotalol market in terms of revenue (US$ million) and, where applicable, sales volume (m units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/m units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Sotalol Market by Company
Shaanxi Hanjiang Pharmaceutical Group
GSK
Bayer
Samarth Pharma Pvt. Ltd.
Cipla Limited
Cambrex
Bristol-Myers Squibb (BMS)
Arevipharma
Arbor Pharmaceuticals
Sotalol Segment by Type
40mg Sotalol
80mg Sotalol
Sotalol Segment by Application
Sustained Ventricular Tachycardia
Atrial Fibrillation/Flutter
Sotalol Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sotalol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sotalol and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sotalol.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Sotalol manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Sotalol by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Sotalol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 40mg Sotalol
- 80mg Sotalol
Applications
- Sustained Ventricular Tachycardia
- Atrial Fibrillation/Flutter
Companies covered
- Shaanxi Hanjiang Pharmaceutical Group
- GSK
- Bayer
- Samarth Pharma Pvt. Ltd.
- Cipla Limited
- Cambrex
- Bristol-Myers Squibb (BMS)
- Arevipharma
- Arbor Pharmaceuticals
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Sotalol Market Size (2021-2032)
- 2.2.2 Global Sotalol Sales (2021-2032)
- 2.2.3 Global Sotalol Market Average Price (2021-2032)
- 2.3 Sotalol by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 40mg Sotalol
- 2.3.3 80mg Sotalol
- 2.4 Sotalol by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Sustained Ventricular Tachycardia
- 2.4.3 Atrial Fibrillation/Flutter
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Sotalol Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Sotalol Sales (m units) of Manufacturers (2021-2026)
- 3.3 Global Sotalol Revenue of Manufacturers (2021-2026)
- 3.4 Global Sotalol Average Price by Manufacturers (2021-2026)
- 3.5 Global Sotalol Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Sotalol, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Sotalol, Product Type & Application
- 3.8 Global Manufacturers of Sotalol, Established Date
- 3.9 Global Sotalol Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Shaanxi Hanjiang Pharmaceutical Group
- 4.1.1 Shaanxi Hanjiang Pharmaceutical Group Company Information
- 4.1.2 Shaanxi Hanjiang Pharmaceutical Group Business Overview
- 4.1.3 Shaanxi Hanjiang Pharmaceutical Group Sotalol Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Shaanxi Hanjiang Pharmaceutical Group Sotalol Product Portfolio
- 4.1.5 Shaanxi Hanjiang Pharmaceutical Group Recent Developments
- 4.2 GSK
- 4.2.1 GSK Company Information
- 4.2.2 GSK Business Overview
- 4.2.3 GSK Sotalol Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 GSK Sotalol Product Portfolio
- 4.2.5 GSK Recent Developments
- 4.3 Bayer
- 4.3.1 Bayer Company Information
- 4.3.2 Bayer Business Overview
- 4.3.3 Bayer Sotalol Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Bayer Sotalol Product Portfolio
- 4.3.5 Bayer Recent Developments
- 4.4 Samarth Pharma Pvt. Ltd.
- 4.4.1 Samarth Pharma Pvt. Ltd. Company Information
- 4.4.2 Samarth Pharma Pvt. Ltd. Business Overview
- 4.4.3 Samarth Pharma Pvt. Ltd. Sotalol Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Samarth Pharma Pvt. Ltd. Sotalol Product Portfolio
- 4.4.5 Samarth Pharma Pvt. Ltd. Recent Developments
- 4.5 Cipla Limited
- 4.5.1 Cipla Limited Company Information
- 4.5.2 Cipla Limited Business Overview
- 4.5.3 Cipla Limited Sotalol Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Cipla Limited Sotalol Product Portfolio
- 4.5.5 Cipla Limited Recent Developments
- 4.6 Cambrex
- 4.6.1 Cambrex Company Information
- 4.6.2 Cambrex Business Overview
- 4.6.3 Cambrex Sotalol Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Cambrex Sotalol Product Portfolio
- 4.6.5 Cambrex Recent Developments
- 4.7 Bristol-Myers Squibb (BMS)
- 4.7.1 Bristol-Myers Squibb (BMS) Company Information
- 4.7.2 Bristol-Myers Squibb (BMS) Business Overview
- 4.7.3 Bristol-Myers Squibb (BMS) Sotalol Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Bristol-Myers Squibb (BMS) Sotalol Product Portfolio
- 4.7.5 Bristol-Myers Squibb (BMS) Recent Developments
- 4.8 Arevipharma
- 4.8.1 Arevipharma Company Information
- 4.8.2 Arevipharma Business Overview
- 4.8.3 Arevipharma Sotalol Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Arevipharma Sotalol Product Portfolio
- 4.8.5 Arevipharma Recent Developments
- 4.9 Arbor Pharmaceuticals
- 4.9.1 Arbor Pharmaceuticals Company Information
- 4.9.2 Arbor Pharmaceuticals Business Overview
- 4.9.3 Arbor Pharmaceuticals Sotalol Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Arbor Pharmaceuticals Sotalol Product Portfolio
- 4.9.5 Arbor Pharmaceuticals Recent Developments
5 Global Sotalol Market Scenario by Region
- 5.1 Global Sotalol Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Sotalol Sales by Region: 2021-2032
- 5.2.1 Global Sotalol Sales by Region: 2021-2026
- 5.2.2 Global Sotalol Sales by Region: 2027-2032
- 5.3 Global Sotalol Revenue by Region: 2021-2032
- 5.3.1 Global Sotalol Revenue by Region: 2021-2026
- 5.3.2 Global Sotalol Revenue by Region: 2027-2032
- 5.4 North America Sotalol Market Facts & Figures by Country
- 5.4.1 North America Sotalol Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Sotalol Sales by Country (2021-2032)
- 5.4.3 North America Sotalol Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Sotalol Market Facts & Figures by Country
- 5.5.1 Europe Sotalol Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Sotalol Sales by Country (2021-2032)
- 5.5.3 Europe Sotalol Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Sotalol Market Facts & Figures by Country
- 5.6.1 Asia Pacific Sotalol Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Sotalol Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Sotalol Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Sotalol Market Facts & Figures by Country
- 5.7.1 South America Sotalol Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Sotalol Sales by Country (2021-2032)
- 5.7.3 South America Sotalol Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Sotalol Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Sotalol Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Sotalol Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Sotalol Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Sotalol Sales by Type (2021-2032)
- 6.1.1 Global Sotalol Sales by Type (2021-2032) & (m units)
- 6.1.2 Global Sotalol Sales Market Share by Type (2021-2032)
- 6.2 Global Sotalol Revenue by Type (2021-2032)
- 6.2.1 Global Sotalol Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Sotalol Revenue Market Share by Type (2021-2032)
- 6.3 Global Sotalol Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Sotalol Sales by Application (2021-2032)
- 7.1.1 Global Sotalol Sales by Application (2021-2032) & (m units)
- 7.1.2 Global Sotalol Sales Market Share by Application (2021-2032)
- 7.2 Global Sotalol Revenue by Application (2021-2032)
- 7.2.1 Global Sotalol Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Sotalol Revenue Market Share by Application (2021-2032)
- 7.3 Global Sotalol Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Sotalol Value Chain Analysis
- 8.1.1 Sotalol Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Sotalol Production Mode & Process
- 8.2 Sotalol Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Sotalol Distributors
- 8.2.3 Sotalol Customers
9 Global Sotalol Analyzing Market Dynamics
- 9.1 Sotalol Industry Trends
- 9.2 Sotalol Industry Drivers
- 9.3 Sotalol Industry Opportunities and Challenges
- 9.4 Sotalol Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst